BBCMF (Lir Life Sciences) ROE % Adjusted to Book Value: -13.65% (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences ROE % Adjusted to Book Value?

Lir Life Sciences BBCMF -80.00% 15 ROE % Adjusted to Book Value is -13.65% as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Lir Life Sciences's ROE % for the quarter that ended in Jan. 2026 was -682.67%. Lir Life Sciences's PB Ratio for the quarter that ended in Jan. 2026 was 50.00. Lir Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2026 was -13.65%.

Lir Life Sciences ROE % Adjusted to Book Value Related Terms

Lir Life Sciences ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences ROE % Adjusted to Book Value Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
ROE % Adjusted to Book Value
0.00 0.00

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
ROE % Adjusted to Book Value Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -13.65

BBCMF vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Lir Life Sciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lir Life Sciences ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lir Life Sciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Lir Life Sciences's ROE % Adjusted to Book Value falls into.


BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences ROE % Adjusted to Book Value Calculation

Lir Life Sciences's ROE % Adjusted to Book Value for the fiscal year that ended in Apr. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Lir Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-682.67% / 50.00
=-13.65%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -13.65% mean?
Lir Life Sciences (BBCMF) has a ROE % Adjusted to Book Value of -13.65% as of Jan. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' ROE % Adjusted to Book Value too high?
Lir Life Sciences' current ROE % Adjusted to Book Value is -13.65%. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' ROE % Adjusted to Book Value compare to VRTX and REGN?
Lir Life Sciences' ROE % Adjusted to Book Value of -13.65% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current ROE % Adjusted to Book Value is -13.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current ROE % Adjusted to Book Value of -13.65%. The current ROE % Adjusted to Book Value is -13.65%. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current ROE % Adjusted to Book Value is -13.65% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price